Preview

Obstetrics, Gynecology and Reproduction

Advanced search

MANAGEMENT OF PATIENTS WITH CERVICAL INSUFFICIENCY

https://doi.org/10.17749/2313-7347.2016.10.2.064-069

Full Text:

Abstract

The article presents a literature review on methods of diagnosis, therapy and management of patients with isthmic-cervical insufficiency. Risk factors for the development of isthmic-cervical insufficiency are the acquired and congenital anomalies of the cervix. The diagnosis can be made only during pregnancy. Shortening of cervical length <25 mm before 24 weeks indicates the presence of ICN and the significant risk of miscarriage. Initial evaluation of the cervical length is from 14 weeks. When finding a shortening of the length of the closed part of the cervical canal is less than 25 mm the treatment of choice is surgical correction. When the cervical length more than 25 mm prophylactically from 19 to 32 weeks assigned to micronized progesterone 200 mg vagina. In identifying ICN after 24 weeks, the method of choice is the appointment of micronized progesterone and the installation of an unloading obstetric pessary. The use of a differentiated algorithm of management of patients with ICN reduces the chance of unexpected premature birth and neonatal morbidity and mortality.

About the Authors

S. A. Levakov
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation

MD, Professor, Head of the Department of Obstetrics and Gynecology IPO,

ul. Trubetskaya, 8, p. 2, Moscow, 119048



E. I. Borovkova
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation

MD, Professor, Department of Obstetrics and Gynecology IPO,

ul. Trubetskaya, 8, p. 2, Moscow, 119048



N. A. Sheshukova
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation

MD, Professor, Department of Obstetrics and Gynecology IPO,

ul. Trubetskaya, 8, p. 2, Moscow, 119048



I. M. Borovkov
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation

student,

ul. Trubetskaya, 8, p. 2, Moscow, 119048



References

1. The Ministry of Health of Russia Order dated November 12, 2012 № 572n "On approval of the provision of medical care on the profile of" Obstetrics and Gynecology (except for the use of assisted reproductive technologies)" [Prikaz Minzdrava Rossii ot 12 noyabrya 2012 g. № 572n «Ob utverzhdenii Poryadka okazaniya meditsinskoi pomoshchi po profilyu «akusherstvo i ginekologiya (za isklyucheniem ispol'zovaniya vspomogatel'nykh reproduktivnykh tekhnologii)» (in Russian)]. URL: https://www.rosminzdrav.ru/documents/5828-prikaz. Accessed: 15.01.16.

2. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014; 123: 372.

3. Alfirevic Z., Owen J., Carreras Moratonas E. et al. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol. 2013; 41: 146.

4. Berghella V., Rafael T.J., Szychowski J.M. et al. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol. 2011; 117: 663.

5. Berghella V., Mackeen A.D. Cervical length screening with ultrasound-indicated cerclage compared with history-indicated cerclage for prevention of preterm birth: a meta-analysis. Obstet Gynecol. 2011; 118: 148.

6. Berghella V., Figueroa D., Szychowski J.M. et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol. 2010; 202: 351.e1.

7. Conde-Agudelo A., Romero R., Nicolaides K. et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013; 208: 42.e1.

8. Chan Y.Y., Jayaprakasan K., Tan A. et al. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011; 38: 371.

9. Ehsanipoor R.M., Seligman N.S., Saccone G. et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015; 126: 125.

10. Goya M., Pratcorona L., Merced C. et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet. 2012; 379: 1800.

11. Gorski L.A., Huang W.H., Iriye B.K., Hancock J. Clinical implication of intra-amniotic sludge on ultrasound in patients with cervical cerclage. Ultrasound Obstet Gynecol. 2010; 36: 482.

12. Iams J.D., Cebrik D., Lynch C. et al. The rate of cervical change and the phenotype of spontaneous preterm birth. Am J Obstet Gynecol. 2011; 205: 130.

13. Rackow B.W., Arici A. Reproductive performance of women with müllerian anomalies. Curr Opin Obstet Gynecol. 2007; 19: 229.

14. Romero R., Lockwood C.J. Pathogenesis of spontaneous preterm labor. In: Creasy & Resnik's Maternal Fetal Medicine / Creasy R.K., Resnik R., Iams J.D., Lockwood C.J., Moore T.R. (Eds). Saunders. 2009.

15. Rafael T.J., Mackeen A.D., Berghella V. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasoundindicated cerclage. Am J Perinatol. 2011; 28: 389.

16. Shah P.S., Zao J., Knowledge Synthesis Group of Determinants of preterm / LBW births. Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG. 2009; 116: 1425.

17. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol. 2012; 206: 376.

18. Vousden N., Hezelgrave N., Carter J. et al. Prior ultrasound-indicated cerclage: how should we manage the next pregnancy? Eur J Obstet Gynecol Reprod Biol. 2015; 188: 129.

19. Vyas N.A., Vink J.S., Ghidini A. et al. Risk factors for cervical insufficiency after term delivery. Am J Obstet Gynecol. 2006; 195: 787.

20. Warren J.E., Silver R.M., Dalton J. et al. Collagen 1Alpha1 and transforming growth factor-beta polymorphisms in women with cervical insufficiency. Obstet Gynecol. 2007; 110: 619.


For citation:


Levakov S.A., Borovkova E.I., Sheshukova N.A., Borovkov I.M. MANAGEMENT OF PATIENTS WITH CERVICAL INSUFFICIENCY. Obstetrics, Gynecology and Reproduction. 2016;10(2):64-69. (In Russ.) https://doi.org/10.17749/2313-7347.2016.10.2.064-069

Views: 192


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)